The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study | Zendy

Su-Jung Chen | Zendy; Chiu-Mei Yeh | Zendy; TzeFan Chao | Zendy; ChiaJen Liu | Zendy; Kang-Ling Wang | Zendy; TzengJi Chen | Zendy; Pesus Chou | Zendy; FuDer Wang | Zendy

Open Access

The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study

Author(s) -

Su-Jung Chen,

Chiu-Mei Yeh,

TzeFan Chao,

ChiaJen Liu,

Kang-Ling Wang,

TzengJi Chen,

Pesus Chou,

FuDer Wang

Publication year - 2015

Publication title -

sleep

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.222

H-Index - 207

eISSN - 1550-9109

pISSN - 0161-8105

DOI - 10.5665/sleep.4808

Subject(s) - medicine , copd , odds ratio , benzodiazepine , case control study , confidence interval , population , risk factor , respiratory failure , environmental health , receptor

Insomnia is prevalent in patients with chronic obstructive pulmonary disease (COPD), and benzodiazepine receptor agonists (BZRAs) are the most commonly used drugs despite their adverse effects on respiratory function. The aim of this study was to investigate whether the use of BZRAs was associated with an increased risk of respiratory failure (RF) in COPD patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research